Apexus: Implementation III: Orphan Drug Exclusion

Apexus: Implementation III: Orphan Drug Exclusion

Apexus: Implementation III: Orphan Drug Exclusion

Apexus: Implementation III: Orphan Drug Exclusion

Clicl here for video

DOT
Defines the Orphan Drug Exclusion, which entities are subject to its requirements and approaches for compliance. This module will take approximately 9 minutes to complete. This course is one of the nineteen courses in the Apexus 340B University OnDemand Curriculum.

COURSE INFORMATION

Apexus 9 minValid for 12 monthsCreated 2020-11-04Updated 2020-11-04

Course Objectives

  • Define the Orphan Drug Exclusion with regard to the 340B Drug Pricing Program
  • Explain how HRSA facilities communication about the Orphan Drug Exclusion
  • Describe approaches used by covered entities to operationalize the Orphan Drug Exclusion

Take course now!
div#stuning-header .dfd-stuning-header-bg-container {background-image: url(https://medtrainer.com/wp-content/uploads/2017/11/terms-bg.jpg);background-size: cover;background-position: center center;background-attachment: initial;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 550px;}